Kidney Cancer Trial, Recruiting (NCT05890781)

Kidney Cancer Trial, Recruiting NCT05890781 Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05890781 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You were 25 years old or younger when diagnosed — though for brain tumors (specifically malignant gliomas) and kidney tumors, there is no upper age limit
You have a suspected or confirmed diagnosis of one of these conditions, at any stage: a brain tumor, a kidney (renal) tumor, neuroblastoma, or a sarcoma
You (if an adult) or your parent/guardian (if you are a child) are able to understand, sign, and date a consent form before any study procedures begin, and are willing to attend study visits and follow the study plan
You are covered by a social security or health insurance system (confirm with trial site)

Who may not be able to join:

You have a type of cancer or tumor that is not one of the four listed above (brain tumors, kidney tumors, neuroblastoma, or sarcomas)
You are an adult who is unable to give consent yourself, or if you are a child, your parents or guardians are unable to give consent on your behalf
You are currently under a court order or official decision that restricts your freedom (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 (0)1 42 11 55 31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05890781

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +33 (0)1 42 11 55 31

More information: https://clinicaltrials.gov/study/NCT05890781

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You were 25 years old or younger when diagnosed — though for brain tumors (specifically malignant gliomas) and kidney tumors, there is no upper age limit
You have a suspected or confirmed diagnosis of one of these conditions, at any stage: a brain tumor, a kidney (renal) tumor, neuroblastoma, or a sarcoma
You (if an adult) or your parent/guardian (if you are a child) are able to understand, sign, and date a consent form before any study procedures begin, and are willing to attend study visits and follow the study plan
You are covered by a social security or health insurance system (confirm with trial site)

Who may not be able to join:

You have a type of cancer or tumor that is not one of the four listed above (brain tumors, kidney tumors, neuroblastoma, or sarcomas)
You are an adult who is unable to give consent yourself, or if you are a child, your parents or guardians are unable to give consent on your behalf
You are currently under a court order or official decision that restricts your freedom (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Registry

ClinicalTrials.gov

Start date

12 May 2023

Est. completion

1 May 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion of viable and exploitable immune organoids with engrafted tumor cells

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov